{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:07:16Z","timestamp":1786982836728,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T00:00:00Z","timestamp":1714953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T00:00:00Z","timestamp":1714953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Endocrinology and Metabolism Training Coordination Association"},{"DOI":"10.13039\/501100003356","name":"Gazi University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003356","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The liver is known to be protected from steatosis under the influence of high GH\/IGF-1. Cytokeratin 18 (CK18) and insulin-like growth factor binding protein 7 (IGFBP7) increase in liver steatosis and fibrosis. The aim of this study was to use quantitative ultrasound techniques and biochemical markers to assess liver steatosis and liver fibrosis in newly diagnosed acromegaly.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center, cross-sectional study included 23 patients with newly diagnosed acromegaly and 46 age, sex, body mass index (BMI) and waist circumference (WC)-matched controls. Liver steatosis was assessed using tissue attenuation imaging (TAI), and stiffness, indicative of fibrosis, was assessed by shear wave elastography (SWE). Serum IGFBP7 and CK18 were studied by ELISA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The acromegaly group had significantly lower liver steatosis (p\u2009=\u20090.006) and higher liver stiffness (p\u2009=\u20090.004), serum IGFBP7 (p\u2009=\u20090.048) and CK18 (p\u2009=\u20090.005) levels than the control group. The presence of fibrosis (p\u2009=\u20090.012) was significantly higher in the acromegaly group than in the control group. Moreover, CK18 was positively correlated with liver stiffness, WC, HOMA-IR, HbA1c, and triglyceride. In the acromegaly group, liver steatosis was negatively correlated with GH level. Stepwise multiple linear regression analysis revealed that BMI (p\u2009=\u20090.008) and CK18 (p\u2009=\u20090.015) were independent risk factors for increased liver stiffness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study showed that there was an increased presence of liver fibrosis independent of liver steatosis in newly diagnosed acromegaly. Serum CK18 appears to be a potential marker of increased liver fibrosis in acromegaly.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40618-024-02384-5","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T01:01:27Z","timestamp":1714957287000},"page":"2823-2833","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Quantitative ultrasound techniques and biochemical markers to assess liver steatosis and fibrosis in newly diagnosed acromegaly"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4855-6078","authenticated-orcid":false,"given":"M.","family":"Coskun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. N.","family":"Sendur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Babayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. N.","family":"Cerit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. T.","family":"Cerit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. E.","family":"Altinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Akturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Karakoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. B.","family":"Toruner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,6]]},"reference":[{"issue":"11","key":"2384_CR1","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER, Melmed S et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933\u20133951. https:\/\/doi.org\/10.1210\/jc.2014-2700","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2384_CR2","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1210\/jc.2007-2780","volume":"93","author":"PU Freda","year":"2008","unstructured":"Freda PU, Shen W, Heymsfield SB et al (2008) Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly. J Clin Endocrinol Metab 93(6):2334\u20132343. https:\/\/doi.org\/10.1210\/jc.2007-2780","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2384_CR3","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1210\/jc.2015-1917","volume":"100","author":"CM Reyes-Vidal","year":"2015","unstructured":"Reyes-Vidal CM, Mojahed H, Shen W et al (2015) Adipose tissue redistribution and ectopic lipid deposition in active acromegaly and effects of surgical treatment. J Clin Endocrinol Metab 100(8):2946\u20132955. https:\/\/doi.org\/10.1210\/jc.2015-1917","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2384_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/ejendo\/lvac014","volume":"188","author":"MC Arlien-S\u00f8borg","year":"2023","unstructured":"Arlien-S\u00f8borg MC, Madsen MA, Dal J et al (2023) Ectopic lipid deposition and insulin resistance in patients with GH disorders before and after treatment. Eur J Endocrinol 188(1):78\u201385. https:\/\/doi.org\/10.1093\/ejendo\/lvac014","journal-title":"Eur J Endocrinol"},{"key":"2384_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014212","author":"M Bankir","year":"2019","unstructured":"Bankir M, Sumbul HE, Koc AS, Demirtas D, Acibucu F (2019) Elastography detected solid organ stiffness increased in patients with acromegaly. Medicine (United States). https:\/\/doi.org\/10.1097\/MD.0000000000014212","journal-title":"Medicine (United States)."},{"key":"2384_CR6","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad490","author":"\u0130 Ero\u011flu","year":"2023","unstructured":"Ero\u011flu \u0130, Iremli BG, Idilman IS et al (2023) Nonalcoholic fatty liver disease, liver fibrosis and utility of noninvasive scores in patients with acromegaly. J cli Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgad490","journal-title":"J cli Endocrinol Metab"},{"issue":"5","key":"2384_CR7","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"K Cusi","year":"2022","unstructured":"Cusi K, Isaacs S, Barb D et al (2022) American association of clinical endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 28(5):528\u2013562. https:\/\/doi.org\/10.1016\/j.eprac.2022.03.010. (Co-Sponsored by the American Association)","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"issue":"10","key":"2384_CR8","doi-asserted-by":"publisher","first-page":"e989","DOI":"10.1210\/clinem\/dgad206","volume":"108","author":"P Fellinger","year":"2023","unstructured":"Fellinger P, Beiglb\u00f6ck H, Semmler G et al (2023) Increased GH\/IGF-I axis activity relates to lower hepatic lipids and phosphor metabolism. J Clin Endocrinol Metab 108(10):e989\u2013e997. https:\/\/doi.org\/10.1210\/clinem\/dgad206","journal-title":"J Clin Endocrinol Metab"},{"issue":"10290","key":"2384_CR9","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VWS, Rinella M (2021) Non-alcoholic fatty liver disease. The Lancet 397(10290):2212\u20132224. https:\/\/doi.org\/10.1016\/S0140-6736(20)32511-3","journal-title":"The Lancet"},{"issue":"2","key":"2384_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","volume":"68","author":"E Vilar-Gomez","year":"2018","unstructured":"Vilar-Gomez E, Chalasani N (2018) Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers. J Hepatol 68(2):305\u2013315. https:\/\/doi.org\/10.1016\/j.jhep.2017.11.013","journal-title":"J Hepatol"},{"issue":"12","key":"2384_CR11","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.ultrasmedbio.2018.07.019","volume":"44","author":"A Ozturk","year":"2018","unstructured":"Ozturk A, Grajo JR, Gee MS et al (2018) Quantitative hepatic fat quantification in non-alcoholic fatty liver disease using ultrasound-based techniques: a review of literature and their diagnostic performance. Ultrasound Med Biol 44(12):2461\u20132475. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2018.07.019","journal-title":"Ultrasound Med Biol"},{"issue":"33","key":"2384_CR12","doi-asserted-by":"publisher","first-page":"E29708","DOI":"10.1097\/MD.0000000000029708","volume":"101","author":"AD Ronaszeki","year":"2022","unstructured":"Ronaszeki AD, Budai BK, Csongrady B et al (2022) Tissue attenuation imaging and tissue scatter imaging for quantitative ultrasound evaluation of hepatic steatosis. Medicine (United States) 101(33):E29708. https:\/\/doi.org\/10.1097\/MD.0000000000029708","journal-title":"Medicine (United States)"},{"key":"2384_CR13","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.06.013","author":"JJ Wattacheril","year":"2023","unstructured":"Wattacheril JJ, Abdelmalek MF, Lim JK, Sanyal AJ (2023) AGA clinical practice update on the role of noninvasive biomarkers in the evaluation and management of nonalcoholic fatty liver disease: expert review. Gastroenterology. https:\/\/doi.org\/10.1053\/j.gastro.2023.06.013","journal-title":"Gastroenterology"},{"issue":"8","key":"2384_CR14","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.2337\/db05-1627","volume":"55","author":"A L\u00f3pez-Bermejo","year":"2006","unstructured":"L\u00f3pez-Bermejo A, Khosravi J, Fern\u00e1ndez-Real JM et al (2006) Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1\/MAC25). Diabetes 55(8):2333\u20132339. https:\/\/doi.org\/10.2337\/db05-1627","journal-title":"Diabetes"},{"issue":"2","key":"2384_CR15","doi-asserted-by":"publisher","first-page":"E520","DOI":"10.1210\/clinem\/dgaa792","volume":"106","author":"TL Stanley","year":"2021","unstructured":"Stanley TL, Fourman LT, Zheng I et al (2021) Relationship of IGF-1 and IGF-binding proteins to disease severity and glycemia in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 106(2):E520\u2013E533. https:\/\/doi.org\/10.1210\/clinem\/dgaa792","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20132","key":"2384_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11010-020-03728-4","volume":"469","author":"M Mart\u00ednez-Castillo","year":"2020","unstructured":"Mart\u00ednez-Castillo M, Rosique-Oramas D, Medina-Avila Z et al (2020) Differential production of insulin-like growth factor-binding proteins in liver fibrosis progression. Mol Cell Biochem 469(1\u20132):65\u201375. https:\/\/doi.org\/10.1007\/s11010-020-03728-4","journal-title":"Mol Cell Biochem"},{"key":"2384_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122086","author":"Y Wang","year":"2023","unstructured":"Wang Y, Bo J, Zhao Z, Han Y, Zhang Q, Liu L (2023) Depletion of Igfbp7 alleviates zebrafish NAFLD progression through inhibiting hepatic ferroptosis. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2023.122086","journal-title":"Life Sci"},{"issue":"5","key":"2384_CR18","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/MEG.0000000000001385","volume":"31","author":"SK Darweesh","year":"2019","unstructured":"Darweesh SK, Abdelaziz RA, Abd-Elfatah DS et al (2019) Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients. Eur J Gastroenterol Hepatol 31(5):633\u2013641. https:\/\/doi.org\/10.1097\/MEG.0000000000001385","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2384_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-021-01963-7","author":"F Li","year":"2021","unstructured":"Li F, Lei F, Wen C, Ge Q, Zhu L (2021) Cytokeratin 18 can help predict liver fibrosis in HCV infected patients with type 2 diabetes mellitus. BMC Gastroenterol. https:\/\/doi.org\/10.1186\/s12876-021-01963-7","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"2384_CR20","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.dsx.2019.01.005","volume":"13","author":"M Safarian","year":"2019","unstructured":"Safarian M, Mohammadpour S, Shafiee M et al (2019) Effect of diet-induced weight loss on cytokeratin-18 levels in overweight and obese patients with liver fibrosis. Diabetes Metab Syndr 13(2):989\u2013994. https:\/\/doi.org\/10.1016\/j.dsx.2019.01.005","journal-title":"Diabetes Metab Syndr"},{"issue":"11","key":"2384_CR21","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1097\/MEG.0000000000002176","volume":"33","author":"T Tada","year":"2021","unstructured":"Tada T, Saibara T, Ono M et al (2021) Predictive value of cytokeratin-18 fragment levels for diagnosing steatohepatitis in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 33(11):1451\u20131468. https:\/\/doi.org\/10.1097\/MEG.0000000000002176","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"2384_CR22","doi-asserted-by":"publisher","first-page":"E937","DOI":"10.1210\/clinem\/dgz096","volume":"105","author":"A Giustina","year":"2020","unstructured":"Giustina A, Barkan A, Beckers A et al (2020) A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. J Clin Endocrinol Metab 105(4):E937\u2013E946. https:\/\/doi.org\/10.1210\/clinem\/dgz096","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2384_CR23","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.5114\/aoms\/152921","volume":"18","author":"P Dobrowolski","year":"2022","unstructured":"Dobrowolski P, Prejbisz A, Kurylowicz A et al (2022) Metabolic syndrome a new definition and management guidelines. Arch Med Sci 18(5):1133\u20131156. https:\/\/doi.org\/10.5114\/aoms\/152921","journal-title":"Arch Med Sci"},{"issue":"2","key":"2384_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1148\/radiol.2020192437","volume":"296","author":"RG Barr","year":"2020","unstructured":"Barr RG, Wilson SR, Rubens D, Garcia-Tsao G, Ferraioli G (2020) Update to the society of radiologists in ultrasound liver elastography consensus statement. Radiology 296(2):263\u2013274. https:\/\/doi.org\/10.1148\/radiol.2020192437","journal-title":"Radiology"},{"issue":"2","key":"2384_CR25","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1177\/08465371221123696","volume":"74","author":"HN \u015eendur","year":"2023","unstructured":"\u015eendur HN, \u00d6zdemir Kalkan D, Cerit MN, Kalkan G, \u015eendur AB, \u00d6zhan OS (2023) Hepatic fat quantification with novel ultrasound based techniques: a diagnostic performance study using magnetic resonance imaging proton density fat fraction as reference standard. Can Assoc Radiol J 74(2):362\u2013369. https:\/\/doi.org\/10.1177\/08465371221123696","journal-title":"Can Assoc Radiol J"},{"issue":"11","key":"2384_CR26","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1210\/jc.2017-01210","volume":"102","author":"MA Bredella","year":"2017","unstructured":"Bredella MA, Schorr M, Dichtel LE et al (2017) Body composition and ectopic lipid changes with biochemical control of acromegaly. J Clin Endocrinol Metab 102(11):4218\u20134225. https:\/\/doi.org\/10.1210\/jc.2017-01210","journal-title":"J Clin Endocrinol Metab"},{"key":"2384_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5421961","author":"A Ciresi","year":"2018","unstructured":"Ciresi A, Guarnotta V, Campo D, Giordano C (2018) Hepatic steatosis index in acromegaly: correlation with insulin resistance regardless of the disease control. Int J Endocrinol. https:\/\/doi.org\/10.1155\/2018\/5421961","journal-title":"Int J Endocrinol"},{"issue":"4","key":"2384_CR28","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/edm2.90","volume":"2","author":"A Koutsou-Tassopoulou","year":"2019","unstructured":"Koutsou-Tassopoulou A, Papapostoli-Sklavounou I, Krawczyk M et al (2019) Hepatic steatosis in patients with acromegaly. Endocrinol Diabetes Metab 2(4):90. https:\/\/doi.org\/10.1002\/edm2.90","journal-title":"Endocrinol Diabetes Metab"},{"issue":"4","key":"2384_CR29","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/jum.16048","volume":"42","author":"HN \u015eendur","year":"2023","unstructured":"\u015eendur HN, Cerit MN, Ibrahimkhanli N, \u015eendur AB, \u00d6zhan OS (2023) Interobserver variability in ultrasound-based liver fat quantification. J Ultrasound Med 42(4):833\u2013841. https:\/\/doi.org\/10.1002\/jum.16048","journal-title":"J Ultrasound Med"},{"issue":"9","key":"2384_CR30","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1007\/s00261-021-03269-4","volume":"47","author":"A Ozturk","year":"2022","unstructured":"Ozturk A, Olson MC, Samir AE, Venkatesh SK (2022) Liver fibrosis assessment: MR and US elastography. Abdom Radiol 47(9):3037\u20133050. https:\/\/doi.org\/10.1007\/s00261-021-03269-4","journal-title":"Abdom Radiol"},{"issue":"2","key":"2384_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1152\/ajpgi.00413.2004","volume":"289","author":"S Fruchtman","year":"2005","unstructured":"Fruchtman S, Simmons JG, Michaylira CZ et al (2005) Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells. Am J Physiol\u2014Gastrointest Liver Physiol 289(2):52\u20132. https:\/\/doi.org\/10.1152\/ajpgi.00413.2004","journal-title":"Am J Physiol\u2014Gastrointest Liver Physiol"},{"issue":"1","key":"2384_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1055\/a-2015-1359","volume":"43","author":"M Oxley","year":"2023","unstructured":"Oxley M, Francis H, Sato K (2023) Growth hormone signaling in liver diseases: therapeutic potentials and controversies. Semin Liver Dis 43(1):24\u201330. https:\/\/doi.org\/10.1055\/a-2015-1359","journal-title":"Semin Liver Dis"},{"issue":"6","key":"2384_CR33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1530\/EJE-20-0019","volume":"182","author":"D Esposito","year":"2020","unstructured":"Esposito D, Ragnarsson O, Johannsson G, Olsson DS (2020) Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality. Eur J Endocrinol 182(6):523\u2013531. https:\/\/doi.org\/10.1530\/EJE-20-0019","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2384_CR34","doi-asserted-by":"publisher","first-page":"T139","DOI":"10.1530\/JME-18-0016","volume":"61","author":"DR Clemmons","year":"2018","unstructured":"Clemmons DR (2018) Role of igf-binding proteins in regulating igf responses to changes in metabolism. J Mol Endocrinol 61(1):T139\u2013T169. https:\/\/doi.org\/10.1530\/JME-18-0016","journal-title":"J Mol Endocrinol"},{"issue":"26","key":"2384_CR35","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.3748\/wjg.15.3246","volume":"15","author":"LX Liu","year":"2009","unstructured":"Liu LX, Huang S, Zhang QQ et al (2009) Insulin-like growth factor binding protein-7 induces activation and transdifferentiation of hepatic stellate cells in vitro. World J Gastroenterol 15(26):3246\u20133253. https:\/\/doi.org\/10.3748\/wjg.15.3246","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2384_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2004.06.032","volume":"214","author":"S Linder","year":"2004","unstructured":"Linder S, Havelka AM, Ueno T, Shoshan MC (2004) Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker. Cancer Lett 214(1):1\u20139. https:\/\/doi.org\/10.1016\/j.canlet.2004.06.032","journal-title":"Cancer Lett"},{"issue":"1","key":"2384_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.7570\/JOMES21062","volume":"31","author":"VGR Gangireddy","year":"2022","unstructured":"Gangireddy VGR, Pilkerton C, Xiang J, Tinajero R, Ashcraft AM (2022) Hepatic fibrosis and steatosis in metabolic syndrome. J Obes Metab Syndr 31(1):61\u201369. https:\/\/doi.org\/10.7570\/JOMES21062","journal-title":"J Obes Metab Syndr"},{"issue":"11","key":"2384_CR38","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1210\/jc.2014-2242","volume":"99","author":"Y Winhofer","year":"2014","unstructured":"Winhofer Y, Wolf P, Kr\u0161\u0161\u00e1k M et al (2014) No evidence of ectopic lipid accumulation in the pathophysiology of the acromegalic cardiomyopathy. J Clin Endocrinol Metab 99(11):4299\u20134306. https:\/\/doi.org\/10.1210\/jc.2014-2242","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2384_CR39","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1210\/er.2002-0022","volume":"25","author":"A Colao","year":"2004","unstructured":"Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102\u2013152. https:\/\/doi.org\/10.1210\/er.2002-0022","journal-title":"Endocr Rev"},{"issue":"3","key":"2384_CR40","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.hfc.2019.03.001","volume":"15","author":"A Colao","year":"2019","unstructured":"Colao A, Grasso LFS, Di Somma C, Pivonello R (2019) Acromegaly and heart failure. Heart Fail Clin 15(3):399\u2013408. https:\/\/doi.org\/10.1016\/j.hfc.2019.03.001","journal-title":"Heart Fail Clin"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02384-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-024-02384-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-024-02384-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T06:04:43Z","timestamp":1728885883000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-024-02384-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,6]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["2384"],"URL":"https:\/\/doi.org\/10.1007\/s40618-024-02384-5","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,6]]},"assertion":[{"value":"30 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee by the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}